WallStreetZenWallStreetZen

NASDAQ: FULC
Fulcrum Therapeutics Inc Earnings & Revenue

FULC past revenue growth

How has FULC's revenue growth performed historically?
Company
-37.95%
Industry
91.53%
Market
19.5%
FULC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FULC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

FULC earnings and revenue history

Current Revenue
$2.5M
Current Earnings
-$99.4M
Current Profit Margin
-3,961.2%

FULC Return on Equity

Current Company
-40.6%
Current Industry
16.8%
Current Market
28.2%
FULC's Return on Equity (-40.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when FULC announces earnings.

FULC Return on Assets

Current Company
-37.2%
Current Industry
3.2%
FULC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FULC Return on Capital Employed

Current Company
-44.81%
Current Industry
-42.4%
FULC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FULC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FULC$2.51M-$97.34M-$99.43M+35.25%N/A
THRD$0.00-$28.88M-$29.60MN/AN/A
EYPT$50.02M-$77.74M-$78.92M+54.65%N/A
LXRX$2.31M-$176.77M-$193.58M-45.27%N/A
HRTX$132.10M-$77.58M-$80.95M+6.26%N/A

FULC earnings dates

Next earnings date
Aug 1, 2024

Fulcrum Therapeutics Earnings & Revenue FAQ

What were FULC's earnings last quarter?

On Invalid Date, Fulcrum Therapeutics (NASDAQ: FULC) reported Q1 2024 earnings per share (EPS) of -$0.43, up 4.88% year over year. Total Fulcrum Therapeutics earnings for the quarter were -$26.87 million. In the same quarter last year, Fulcrum Therapeutics's earnings per share (EPS) was -$0.41.

If you're new to stock investing, here's how to buy Fulcrum Therapeutics stock.

What was FULC's earnings growth in the past year?

As of Q3 2024, Fulcrum Therapeutics's earnings has grown year over year. Fulcrum Therapeutics's earnings in the past year totalled -$99.43 million.

What is FULC's earnings date?

Fulcrum Therapeutics's earnings date is Invalid Date. Add FULC to your watchlist to be reminded of FULC's next earnings announcement.

What was FULC's revenue last quarter?

On Invalid Date, Fulcrum Therapeutics (NASDAQ: FULC) reported Q1 2024 revenue of $0.00 up 100% year over year. In the same quarter last year, Fulcrum Therapeutics's revenue was $295.00 thousand.

What was FULC's revenue growth in the past year?

As of Q3 2024, Fulcrum Therapeutics's revenue has grown -37.95% year over year. This is 129.47 percentage points lower than the US Biotechnology industry revenue growth rate of 91.53%. Fulcrum Therapeutics's revenue in the past year totalled $2.51 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.